Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending November 22, 2020 One-third of critical illness survivors emerge from ICU with functional deterioration, COVID-19 burdens follow patients after discharge, More must reads Must reads for theWeek ending November 15, 2020 MDD: The importance of psychosocial functioning recovery, Abnormal lipid levels may correlate with suicide attempts in early MDD, Familial coaggregation between MDD and metabolic and cerebrocardiovascular diseases, Emotional memory retrieval before electroconvulsive therapy not effective in MDD, Diabetes linked to increased risk for MDD in women than in men, More must readsMust reads for theWeek ending November 8, 2020 COVID-19 in pregnancy raises risk of preterm birth and severe disease, New case suggestive of in utero SARS-CoV-2 transmission, More must readsMust reads for theWeek ending November 1, 2020 Risk factors for QTc prolongation during amisulpride therapy in schizophrenia, Schizophrenia: Reinitiating clozapine can be considered in patients who have previously discontinued it, Elevated IL-18 levels in patients with schizophrenia, Schizophrenia: Antipsychotic choice may influence driving-related cognitive performance, Treatment-resistant schizophrenia: Is slower-than-recommended titration of clozapine beneficial?, More must readsMust reads for theWeek ending October 25, 2020 Cardiogenic shock rate soars in COVID-positive ACS, COVID-19 experience forced residents to quickly improve patient communication skills, Older age, r/r disease in lymphoma patients tied to increased COVID-19 death rate, National lung cancer screening guidelines may miss younger African American individuals at high risk, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »
